Early real-world outcomes in patients with neovascular Age-related Macular Degeneration (nAMD) treated with Faricimab

被引：0
|
作者：
Raslan, Walid [1 ]
Younis, Saad [1 ]
Fabozzi, Lorenzo [2 ]
Hassan, Islam [1 ]
Palmieri, Filomena [1 ]
机构：
[1] Western Eye Hosp London, London, England
[2] Moorfields Eye Hosp NHS Fdn Trust London, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2023年 / 64卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration
    Hang, Abraham
    Ngo, Taylor
    Virk, Jaipreet Singh
    Moussa, Kareem
    Moshiri, Ala
    Emami-Naeini, Parisa
    Park, Susanna S.
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3781 - 3789
  • [22] Real-World 1-Year Outcomes of Treatment- Intensive Neovascular Age-Related Macular Degeneration Switched to Faricimab
    Sim, Sing Yue
    Chalkiadaki, Evangelia
    Koutsocheras, Georgios
    Nicholson, Luke
    Sivaprasad, Sobha
    Patel, Praveen J.
    Selvam, Senthil
    Pal, Bishwanath
    Keane, Pearse A.
    Bhatia, Bhairavi
    Hamilton, Robin
    OPHTHALMOLOGY RETINA, 2025, 9 (01): : 22 - 30
  • [23] Real world utilization of intravitreal faricimab in patients with neovascular age -related macular degeneration
    Garcia, Brisa
    Wang, Angeline
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [24] Eligibility for faricimab in a real-world neovascular age-related macular degeneration population: a cross-sectional study
    Jern, Irene
    Forsell, Sara
    Norberg, Helena
    BMJ OPEN, 2022, 12 (09):
  • [25] OUTCOMES OF PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (NAMD) IN GREECE UNDER RANIBIZUMAB
    Yfantopoulos, J.
    Rouvas, A.
    Chatzaras, A.
    Xanthopoulou, P.
    Theodosiadis, P.
    VALUE IN HEALTH, 2014, 17 (07) : A604 - A604
  • [26] Real-World Management of Neovascular Age-Related Macular Degeneration in the US
    Moshfeghi, Andrew A.
    Rahimy, Ehsan
    Boucher, Nick
    Sherman, Steven
    Silva, Fabiana Q.
    Moini, Hadi
    Pitcher, John D.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [27] Use of Faricimab in the real-world clinical practice for non-treatment naive neovascular age-related macular degeneration patients
    Tran, Donald
    Trung M. Dang
    Moodie, Jonathan
    Luckie, Alan
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 1020 - 1020
  • [28] THE REAL-WORLD EFFICACY AND SAFETY OF FARICIMAB IN BOTH TREATMENT NAiVE AND TREATMENT RESISTANT PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Lloyd, Aimee
    Abugreen, Salwa
    Kurc, Miguel
    Elbalawi, Mahmoud
    EYE, 2024, 38 : 167 - 167
  • [29] Real-world outcomes in patients with neovascular age-related macular degeneration treated with intravitreal vascular endothelial growth factor inhibitors
    Mehta, Hemal
    Tufail, Adnan
    Daien, Vincent
    Lee, Aaron Y.
    Vuong Nguyen
    Ozturk, Mehmet
    Barthelmes, Daniel
    Gillies, Mark C.
    PROGRESS IN RETINAL AND EYE RESEARCH, 2018, 65 : 127 - 146
  • [30] The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study – 6 month results
    Arshad M. Khanani
    Aamir A. Aziz
    Hannah Khan
    Ashwin Gupta
    Ohidul Mojumder
    Aigerim Saulebayeva
    Ashkan M. Abbey
    David R. P. Almeida
    Robert L. Avery
    Himanshu K. Banda
    Mark R. Barakat
    Ramanath Bhandari
    Emmanuel Y. Chang
    Sara J. Haug
    Nikolas J. S. London
    Luke Mein
    Veeral S. Sheth
    Jeremy D. Wolfe
    Michael A. Singer
    Carl J. Danzig
    Eye, 2023, 37 : 3574 - 3581
12345